New hope for leukemia patients: Chemo-Free treatment shows promise
NCT ID NCT04747912
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests a new chemotherapy-free treatment for adults with a specific type of leukemia called Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL). The treatment combines three drugs: inotuzumab ozogamicin, dasatinib, and dexamethasone. The goal is to see if this combination can help patients achieve complete remission faster and with fewer side effects than standard chemotherapy. The trial is currently recruiting 25 participants who have not yet received treatment.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- inotuzumab ozogamicin (Besponsa) combined with dasatinib and dexamethasone
- What this could lead to
- If successful, this could offer a chemotherapy-free option for newly diagnosed Ph+ ALL, leading to faster and deeper remission without the harsh side effects of traditional chemo.
- What could go wrong
- This is a small, early-phase trial with only 25 participants, so results may not apply to everyone. The drug combination may still cause side effects, and long-term safety and effectiveness are not yet known.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACUTE LYMPHOBLASTIC LEUKEMIA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
University of Chicago Medical Center
RECRUITINGChicago, Illinois, 60615, United States
Contact Email: •••••@•••••
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a Low-Dose antifungal shield vulnerable patients from deadly fungal infections?
- Can a gentler chemo prep make stem cell transplants safer for blood cancer patients?
- A simple blood test may reveal hidden infertility risk in young cancer survivors
- Can donor immune cells tame stem cell transplant risks?
- A simple blood draw could spare kids with leukemia from painful bone marrow tests
- Can a smart drug missile tame Hard-to-Treat leukemia?